Caring Brands (CABR) Registration Filing summary

Company overview and business model

• Operates as a wellness consumer products company offering OTC and cosmetic products for skin and hair conditions, including Photocil, Hair Enzyme Booster (JW-700), CB-101, and No Stingz.

• Focuses on clinically validated, patent-protected formulations with established mechanisms of action and commercial stability.

• Products are marketed in India and the US, with expansion plans in Asia, Africa, and other regions through licensing agreements.

• E-commerce and direct-to-consumer sales are core to the distribution strategy, with ongoing development of online platforms.

• Recently separated from Safety Shot, Inc., now operating as a standalone entity with its own management and governance.

Financial performance and metrics

• Reported nominal revenues and net losses: $1,199,353 loss for six months ended June 30, 2025, and $1,517,431 loss for the year ended December 31, 2024.

• Cash and cash equivalents were $73,893 as of June 30, 2025; $468,998 as of December 31, 2024.

• Net proceeds from the IPO expected to be $3.2 million, with additional $2.11 million raised in a 2024 private placement.

• Ongoing need for additional growth capital; going concern risk highlighted by auditors.

Use of proceeds and capital allocation

• Proceeds allocated to product development, manufacturing, marketing, clinical testing, legal/compliance, repayment of related party loans, and general working capital.

• Specific allocations: $1.9M for product development, $700K for marketing, $505K for manufacturing, $310K for legal/compliance, and $250K for related party loans.

• Funds expected to support operations for approximately 12 months.